Cerebrospinal Fluid Calbindin D Concentration as a Biomarker of Cerebellar Disease Progression in Niemann-Pick Type C1 Disease.
about
Fostering collaborative research for rare genetic disease: the example of niemann-pick type C diseaseIntrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trial.Biomarkers in Lysosomal Storage DiseasesProteomic Analysis of Brain and Cerebrospinal Fluid from the Three Major Forms of Neuronal Ceroid Lipofuscinosis Reveals Potential Biomarkers.Miglustat in Niemann-Pick disease type C patients: a review
P2860
Cerebrospinal Fluid Calbindin D Concentration as a Biomarker of Cerebellar Disease Progression in Niemann-Pick Type C1 Disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cerebrospinal Fluid Calbindin ...... Niemann-Pick Type C1 Disease.
@en
Cerebrospinal Fluid Calbindin ...... Niemann-Pick Type C1 Disease.
@nl
type
label
Cerebrospinal Fluid Calbindin ...... Niemann-Pick Type C1 Disease.
@en
Cerebrospinal Fluid Calbindin ...... Niemann-Pick Type C1 Disease.
@nl
prefLabel
Cerebrospinal Fluid Calbindin ...... Niemann-Pick Type C1 Disease.
@en
Cerebrospinal Fluid Calbindin ...... Niemann-Pick Type C1 Disease.
@nl
P2093
P2860
P356
P1476
Cerebrospinal Fluid Calbindin ...... n Niemann-Pick Type C1 Disease
@en
P2093
Alan Remaley
Allison Bradbury
Charles Vite
Christopher Wassif
Forbes Porter
Gary Swain
Jessica Bagel
Kenneth Drobatz
Maria Prociuk
Maureen Sampson
P2860
P304
P356
10.1124/JPET.116.232975
P407
P577
2016-06-15T00:00:00Z